Stem Cell Authority, Ltd. (SCAL)

Stem Cell Authority Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	FY 2007	FY 2006	FY 2005
Period Ending	Aug 31, 2007	Dec 31, 2006	Dec 31, 2005
Net Income	0.95	-0.66	-0.05
Depreciation & Amortization	0.01	-	-
Change in Inventory	-0.03	-	-
Change in Other Net Operating Assets	-0.05	-0.04	-
Operating Cash Flow	0.13	-0.7	-0.05
Capital Expenditures	-0.12	-	-
Investing Cash Flow	-0.12	-	-
Short-Term Debt Issued	-	0.67	0.05
Total Debt Issued	0.11	0.67	0.05
Total Debt Repaid	-0.01	-	-
Net Debt Issued (Repaid)	0.1	0.67	0.05
Issuance of Common Stock	0.01	0.03	-
Financing Cash Flow	0.11	0.7	0.05
Net Cash Flow	0.12	0	-
Free Cash Flow	0.01	-0.7	-0.05
Free Cash Flow Margin	1.28%	-	-
Free Cash Flow Per Share	-	-0.01	-0.00
Levered Free Cash Flow	-	-0.35	-
Unlevered Free Cash Flow	-	-0.33	-
Change in Working Capital	-0.84	-0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.